The dangers of clogged arteries extend well beyond the workings of your heart. Peripheral artery disease makes it difficult ...

The Miami Lakes, Florida-based company presented 12-month results from the SUCCESS PTA study at the Charing Cross Symposium ...

R3 Vascular announced that a doctor treated the first patient in the ELITE-BTK pivotal trial of its drug-eluting ...

The following is a summary of "Impact of Peripheral Arterial Disease on Clinical Outcomes of Patients Undergoing Complex vs ...

Limus-based devices, rather than being a substitute for paclitaxel as they were once seen, are coming of age in peripheral ...

Efemoral Medical announced the presentation of long-term results from the initial 20 patients enrolled across four sites in ...

The global peripheral vascular devices market, valued at USD 4.7 billion in 2022, is projected to expand at a robust CAGR of 6.6%, reaching USD 8.9 billion by 2032, according to Future Market Insights ...

The company said it expects up to $1.5 million in losses this quarter, in part due to legal costs from its dispute with the ...

A specific gut microbiota pattern was found to predict new cardiovascular events in patients with coronary heart disease, ...